Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase(legacy) | 209 |
| Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase(legacy) | 99 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase | 8 | 3 | 1 | 4 | 5 | 2 | 8 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 68 |
| Germany | 30 |
| China | 24 |
| France | 13 |
| Netherlands | 9 |
| Singapore | 8 |
| Vietnam | 6 |
| Australia | 5 |
| Hong Kong SAR China | 2 |
| Greece | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 25 |
| Beijing | 14 |
| Fairfield | 8 |
| Rotterdam | 8 |
| Hanoi | 6 |
| Singapore | 6 |
| Kaleen | 4 |
| Boardman | 3 |
| Nürnberg | 3 |
| Central | 2 |